CV Sciences (CVSI) Operating Leases (2019 - 2026)

CV Sciences (CVSI) reported Operating Leases of $37000.0 for Q1 2026, down 67.83% on a YoY basis from $115000.0 in Q1 2025, and down 63.0% sequentially from $100000.0 in Q4 2025.

CV Sciences (CVSI) Operating Leases (2019 - 2026) Analysis & Trends

CV Sciences (CVSI) has 8 years of Operating Leases data on file, last reported at $37000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 67.83% year-over-year to $37000.0; the trailing twelve-month figure through Mar 2026 stood at $37000.0 (down 67.83% YoY), and the FY2025 full-year result was $100000.0, up 426.32% from the prior year.
  • Operating Leases retreated to $37000.0 in Q1 2026, from $100000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $360000.0 in Q2 2022 to a low of $19000.0 in Q4 2024.
  • A 5-year average of $141200.0 and a median of $125000.0 in 2023 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases slumped 88.44% in 2022 and surged 426.32% in 2025, its largest moves.
  • Tracing CVSI's Operating Leases over 5 years: stood at $188000.0 in 2022, then plunged by 69.15% to $58000.0 in 2023, then tumbled by 67.24% to $19000.0 in 2024, then surged by 426.32% to $100000.0 in 2025, then tumbled by 63.0% to $37000.0 in 2026.
  • Business Quant data shows CVSI's Operating Leases at $37000.0 in Q1 2026, $100000.0 in Q4 2025, and $162000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 162,000.00
Jun 30, 2025 230,000.00
Mar 31, 2025 115,000.00
Dec 31, 2024 19,000.00
Jun 30, 2024 233,000.00
Mar 31, 2024 23,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 92,000.00
Jun 30, 2023 125,000.00
Mar 31, 2023 157,000.00
Dec 31, 2022 188,000.00
Sep 30, 2022 219,000.00
Jun 30, 2022 360,000.00
Jun 30, 2021 3.11 Mn
Mar 31, 2021 3.29 Mn
Dec 31, 2020 3.47 Mn
Sep 30, 2020 3.64 Mn
Jun 30, 2020 8.83 Mn